Page last updated: 2024-08-25
ubenimex and HIV
ubenimex has been researched along with HIV in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Borkowsky, W; Bourinbaiar, AS; Krasinski, K; Lee-Huang, S | 1 |
| Brown, R; Conway, B; Izaguirre, CA; Proulx, P; Pulido-Cejudo, G | 1 |
Other Studies
2 other study(ies) available for ubenimex and HIV
| Article | Year |
|---|---|
Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.
Topics: Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Cell Division; Cell-Free System; Dextran Sulfate; HIV; HIV Infections; Immunity, Cellular; Immunologic Factors; In Vitro Techniques; Leucine; Virus Replication; Zidovudine | 1994 |
Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.
Topics: Anti-HIV Agents; Cytopathogenic Effect, Viral; HIV; HIV Core Protein p24; HIV Infections; Humans; Leucine; Leucyl Aminopeptidase; Protease Inhibitors; Protein Kinase C; Tumor Cells, Cultured | 1997 |